Click to Share
 
 
  1. Latest News
  2. Submit Press Release

fda Press Releases

  + XML/RSS  



By Arentz Law Group
FDA announces public meeting to discuss risks and benefits of Essure birth control
By Arentz Law Group
Arentz Law Group, P.C. is now accepting cases in all 50 states for victims of the Essure implant.
By FDAzilla
Today, FDAzilla unveiled Enforcement Analytics, a ground-breaking data analytics tool that gives industry greater insights into FDA enforcement actions and inspection activity.
By Cure SMA
The SMA drug pipeline has grown dramatically in just over a decade. Of the 17 programs in the pipeline, seven of these are in clinical trials, and two of those are in Phase 3 clinical trials.
By IMMUNE RESPONSE BIOPHARMA INC
Immune Response BioPharma, Inc. Posts 2nd Half and Full Year 2014 Results Finishing the Year Strong with REMUNE HIV/AIDS Vaccine BLA FDA Filing
By American Conference Institute
The American Conference Institute (ACI) is proud to announce that its industry leading FDA Boot Camp conference is returning to New York City on March 10-11, 2015.
By Critical Path Institute
The Critical Path Institute (C-Path) announced today that the U.S.
By Global Pacific Manufacturing Group LLC
GPMG LLC, a medical device consulting firm, has exceeded sales expectations for its medical device ISO 13485 quality system products.
By FDAnews
9th Annual FDA Inspections Summit **Presented by FDAnews** Oct. 22-24, 2014 – Bethesda, MD www.fdanews.com/InspectionsSummitPR1
By marcus evans
Inviting Heads, VPs, Directors, Managers, and Specialists of Labeling and Regulatory Affairs from leading pharmaceutical and biotech companies to discuss best practices for generic label documentation
By SanRx®
SanRx Advances Development as Part of Collaboration with Northwest Clinical Research Center in Bellevue, Wa.
By Chemic Laboratories Inc.
Chemic Laboratories Inc. and Brenntag, a global market leader in chemical distribution, today announced the establishment of a formal three-year Joint Cooperation Agreement.
By American Conference Institute
American Conference Institute (“ACI”) is pleased to announce that the 3rd FDA & USDA Compliance Boot Camp, taking place at the InterContinental Chicago Magnificent Mile on September 29-30, 2014 will feature senior government officials from the...
By American Conference Institute
American Conference Institute (ACI) is proud to announce that its industry leading FDA Boot Camp conference is returning to Boston, MA on September 18-19, 2014.
By Alliance for Natural Health USA
Deceptive Labeling Confuses Consumers and Contradicts State Department Policies
By Alliance for Natural Health USA
FDA guidelines are unconstitutional, violate the First Amendment and the Equal Protection Clause, and contravene Congressional intent.
By RxforAmericanHealth
A stance by the Pharmaceutical Research and Manufacturers of America (PhRMA) for the U.S.
By Cambridge Healthtech Institute
Bringing Industry, Academia and Regulatory Authorities Together to Produce Safe and Efficacious Products for the Clinic and Beyond
By TodaysSeniorsNetwork
HHS Secretary urged to act to block needless destruction of safe, authentic personally imported prescription medicines
By cGMP UNIVERSITY INC
This seminar is designed for professionals in in the Medical Device, Pharmaceutical, and Biotech startup companies

All Press Releases

By Cambridge Healthtech Institute
Seventh annual event to focus on technologies and strategies for safe and efficacious products in the clinic
By Urban Chique
Beauty is Purity CEO talks about the importance of only working from qualified facilities
By Pinnacle 21
Industry leader celebrated for his role in evolving the new-drug development and approval process
By UrologyWeb
Never before in the history of medicine has a surgical procedure created so much harm for so little benefit and, for so many years, as the radical prostatectomy.
By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc., Provides FDA BLA Update Remune Likely to Carry Black Box Warning Label & U.S.A. Availability Only
By Arentz Law Group
FDA announces public meeting to discuss risks and benefits of Essure birth control
By Arentz Law Group
Arentz Law Group, P.C. is now accepting cases in all 50 states for victims of the Essure implant.
By Immune Response BioPharma, Inc.
(PR.com)-- Immune Response BioPharma, Inc., today provides an update on Remune and announces the FDA has accepted the Remune HIV/AIDS vaccine BLA (biologics licensing application) for review for therapeutic treatment in adults with HIV/AIDS.
By VEXTEC Corporation
Verification & Validation of Computational Software for Predicting the Durability of Pacemaker Leads
By FDAzilla
Today, FDAzilla unveiled Enforcement Analytics, a ground-breaking data analytics tool that gives industry greater insights into FDA enforcement actions and inspection activity.
By Cure SMA
The SMA drug pipeline has grown dramatically in just over a decade. Of the 17 programs in the pipeline, seven of these are in clinical trials, and two of those are in Phase 3 clinical trials.
By Applied Spectral Imaging Inc.
Carlsbad, CA. – April 16, 2015 – Applied Spectral Imaging (ASI, www.spectral-imaging.com) announced today that it has received clearance from the South Korean Ministry of Food and Drug Safety (MFDS) for its GenASIs HiPath image capture and analysis...
By E-QURE Corp
Dr. Sessler, is an MD that has gained proficiency and 20 years experience in business development and marketing.
By VEXTEC Corporation
The Food and Drug Administration (FDA) will evaluate VEXTEC’s Virtual Life Management (VLM®) for certification as a Medical Device Development Tool (MDDT).
By IMMUNE RESPONSE BIOPHARMA
Immune Response BioPharma, Inc., Today provides an update on REMUNE and announces the FDA has accepted the REMUNE HIV/AIDS vaccine BLA (biologics licensing application) for review for therapeutic treatment in adults with HIV/AIDS.
By Ross Medical Corporation
New control center platform and device offers continuous real-time ECG monitoring and cardiac event detection for patients receiving a hospital like workup in the community.
By Visiongain
London, UK, 12th of February 2015: A new report by visiongain predicts that the world pre-filled syringes and pen injectors/autoinjectors market will reach $4.3bn in 2015.
By Immune Response BioPharma
Immune Response BioPharma, Inc. Announces REMUNE FDA BLA Assignment PDUFA Goal date of December 22nd 2015 for Therapeutic HIV/AIDS Vaccine
By calabasas dental institute
CALABASAS, Calif. —  The Federal Drug Administration has issued a new warning on graft substitutes containing recombinant proteins or synthetic peptides.
By Applied Spectral Imaging Inc.
FDA Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67
By IMMUNE RESPONSE BIOPHARMA INC
Immune Response BioPharma, Inc. Posts 2nd Half and Full Year 2014 Results Finishing the Year Strong with REMUNE HIV/AIDS Vaccine BLA FDA Filing
By IMMUNE RESPONSE BIOPHARMA INC
Immune Response BioPharma, Inc. Files BLA with the FDA for REMUNE HIV/AIDS Vaccine Marketing Approval for Therapeutic HIV/AIDS Vaccination
By American Conference Institute
The American Conference Institute (ACI) is proud to announce that its industry leading FDA Boot Camp conference is returning to New York City on March 10-11, 2015.
By NAAFA
NAAFA, BEDA and BingeBehavior.com believe that forcing chain restaurants to include caloric value of every dish and drink on their menus is a wasted effort and could be counterproductive.
By Online Compliance Panel
This webinar will focus on the commonly cited accreditation surveyor citations for facility operations, and what could be done to avoid these citations by facility administrators and managers
By Online Compliance Panel
This webinar will begin by studying the timeline of events in interpreting these events to show the chain of actions and their impact leading to deteriorating state of control and potential injunctive action.
By Datex Corporation
Supply chain software developer Datex Corporation announced new pharmaceutical editions of its award winning warehouse management software for the pharmaceutical, medical device and life sciences industries.
By Datex Corporation
Datex Pharmaceutical Software now includes a suite of features which enables compliance of the new FDA regulation, the Drug Quality Security Act (DQSA).  The FDA Drug Quality and Security Act (DQSA) was signed into law in late 2013.
By Critical Path Institute
The Critical Path Institute (C-Path) announced today that the U.S.
By Global Pacific Manufacturing Group LLC
GPMG LLC, a medical device consulting firm, has exceeded sales expectations for its medical device ISO 13485 quality system products.
By FDAnews
9th Annual FDA Inspections Summit **Presented by FDAnews** Oct. 22-24, 2014 – Bethesda, MD www.fdanews.com/InspectionsSummitPR1
By marcus evans
Inviting Heads, VPs, Directors, Managers, and Specialists of Labeling and Regulatory Affairs from leading pharmaceutical and biotech companies to discuss best practices for generic label documentation
By SanRx®
SanRx Advances Development as Part of Collaboration with Northwest Clinical Research Center in Bellevue, Wa.
By Chemic Laboratories Inc.
Chemic Laboratories Inc. and Brenntag, a global market leader in chemical distribution, today announced the establishment of a formal three-year Joint Cooperation Agreement.
By American Conference Institute
American Conference Institute (“ACI”) is pleased to announce that the 3rd FDA & USDA Compliance Boot Camp, taking place at the InterContinental Chicago Magnificent Mile on September 29-30, 2014 will feature senior government officials from the...
By Public Interest Law Professor John Banzhaf
The WHO has just recommended very tough restrictions on e-cigarettes, including a total ban on their use in public places, regulations to ensure the products contain a standard dose of nicotine, and a ban on sales to children and the use of flavors
By American Conference Institute
American Conference Institute (ACI) is proud to announce that its industry leading FDA Boot Camp conference is returning to Boston, MA on September 18-19, 2014.
By Alliance for Natural Health USA
Deceptive Labeling Confuses Consumers and Contradicts State Department Policies
By Alliance for Natural Health USA
FDA guidelines are unconstitutional, violate the First Amendment and the Equal Protection Clause, and contravene Congressional intent.
By RxforAmericanHealth
A stance by the Pharmaceutical Research and Manufacturers of America (PhRMA) for the U.S.
By Cambridge Healthtech Institute
Bringing Industry, Academia and Regulatory Authorities Together to Produce Safe and Efficacious Products for the Clinic and Beyond
By TodaysSeniorsNetwork
HHS Secretary urged to act to block needless destruction of safe, authentic personally imported prescription medicines
By Q1 Productions
Social Media Implications, Solidifying Data for On-Site Presentation Among Key Topics
By cGMP UNIVERSITY INC
This seminar is designed for professionals in in the Medical Device, Pharmaceutical, and Biotech startup companies
By Q1 Productions
New One-Day Companion Diagnostics Course Added to Meeting Agenda
By Lisa OKeefe
Do you ever think your government isn't interested in what you have to say?
By American Conference Institute
American Conference Institute (ACI) is honored to have all three major associations for the Dietary Supplements Industry –namely the Natural Products Association (NPA), Counsel for Responsible Nutrition (CRN), and American Herbal Products Association...
By Mayday Project
On Thursday, May 22, 2014, Lyme disease victims from around the U.S. will unite at the Infectious Diseases Society of America (IDSA) headquarters for the 2014 Mayday Project protest.
By Public Interest Law Professor John Banzhaf
E-cigarettes may be a public health hazard by permitting users to continue smoking despite workplace smoking bans, encouraging kids to become addicted to nicotine, causing increased indoor air pollution, and encouraging smoking
By Public Interest Law Professor John Banzhaf
In the U.S., the FDA is proposing rules which would do little to rein in a product the agency itself has said pose “acute health risks” which “cannot seriously be questioned” because they contain “toxic chemicals.”


Page:

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share